Urocortin III (human) is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III (human) preferentially binds and activates CRF-R2 and has a discrete central nervous system and peripheral distribution. Urocortin III (human) selectively binds to type 2 CRF receptors with Ki values of 13.5, 21.7, and >100 nM for mCRF2β, rCRF2α, and hCRF1, respectively. Urocortin III (human) mediates somatostatin-dependent negative feedback control of Insulin (human) secretion.

Trientine-2HCl, a chelating agent, is used to treat Wilson's disease by binding up and removing copper in the body.

Peonidin-3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-P-Hydroxybenzoyl-β-D-glucoside}-β-D-glucoside]-5-O-β-D-glucoside